Phage Therapy: Going Temperate?

Rodrigo Monteiro, Diana Priscila Pires, Ana Rita Costa*, Joana Azeredo

*Corresponding author for this work

Research output: Contribution to journalReview articleScientificpeer-review

77 Citations (Scopus)


Strictly lytic phages have been consensually preferred for phage therapy purposes. In contrast, temperate phages have been avoided due to an inherent capacity to mediate transfer of genes between bacteria by specialized transduction – an event that may increase bacterial virulence, for example, by promoting antibiotic resistance. Now, advances in sequencing technologies and synthetic biology are providing new opportunities to explore the use of temperate phages for therapy against bacterial infections. By doing so we can considerably expand our armamentarium against the escalating threat of antibiotic-resistant bacteria.

Original languageEnglish
Pages (from-to)368-378
Number of pages11
JournalTrends in Microbiology
Issue number4
Publication statusPublished - 2019
Externally publishedYes


  • antibiotic resistance
  • CRISPR-Cas
  • phage therapy
  • synthetic biology
  • temperate phages


Dive into the research topics of 'Phage Therapy: Going Temperate?'. Together they form a unique fingerprint.

Cite this